RDY is currently covered by 3 analysts with average potential upside of $12.32 (22.09%) backed by 2 price targets and 20 ratings. Documented since 11-Jun-2019. Analyst's average stock valuation to be materialised ratio is 28.57% with an average time for price targets to be met of 122 days.
Most recent stock forecast was given by BALAJI PRASAD from BARCLAYS on 31-Oct-2022.
Highest price target for RDY is 71, Lowest price target is 48, average price target is 59.5.
Currently, out of the existing stock ratings of RDY - 13 which are a Buy (86.67%), 2 which are a Hold (13.33%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Buy
67
$11.76 (21.29%)
4 months 25 days ago
2/7 (28.57%)
$12.32 (22.09%)
122
What is RDY(Dr. Reddy's Laboratories Limited) average time for price targets to be met?
Which analyst has the current highest performing score on RDY(Dr. Reddy's Laboratories Limited) with a proven track record?